Irish-based pharmaceutical firm Elan today announced it has finished all work necessary for the European launch of its breast cancer drug Myocet.
Elan expects to introduce Myocet in major European markets early in the second quarter of 2001.
The company said that at the time of release of the quarterly results, Elan will give an update on sales of Myocet in the previous quarter.